Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Sarah Bonte"'
Autor:
Melissa Pille, John Avila, Guillem Sanchez Sanchez, Glenn Goetgeluk, Stijn De Munter, Hanne Jansen, Lore Billiet, Karin Weening, Haipeng Xue, Sarah Bonte, Joline Ingels, Laurenz De Cock, Eva Pascal, Lucas Deseins, Tessa Kerre, Tom Taghon, Georges Leclercq, David Vermijlen, Brian Davis, Bart Vandekerckhove
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
The Wiskott–Aldrich syndrome (WAS) is an X-linked primary immune deficiency caused by a mutation in the WAS gene. This leads to altered or absent WAS protein (WASp) expression and function resulting in thrombocytopenia, eczema, recurrent infections
Externí odkaz:
https://doaj.org/article/8e328ea3407848819b605b95f452cf7f
Autor:
Sarah Bonte, Stijn de Munter, Lore Billiet, Glenn Goetgeluk, Joline Ingels, Hanne Jansen, Melissa Pille, Laurenz de Cock, Karin Weening, Tom Taghon, Georges Leclercq, Bart Vandekerckhove, Tessa Kerre
Publikováno v:
OncoImmunology, Vol 10, Iss 1 (2021)
T cell receptor (TCR)-redirected T cells target intracellular antigens such as Wilms’ tumor 1 (WT1), a tumor-associated antigen overexpressed in several malignancies, including acute myeloid leukemia (AML). For both chimeric antigen receptor (CAR)-
Externí odkaz:
https://doaj.org/article/b8d37350b35e4c9e9ca7c2af1a96b344
Autor:
Sarah Bonte, Stijn De Munter, Glenn Goetgeluk, Joline Ingels, Melissa Pille, Lore Billiet, Tom Taghon, Georges Leclercq, Bart Vandekerckhove, Tessa Kerre
Publikováno v:
OncoImmunology, Vol 9, Iss 1 (2020)
Chimeric antigen receptor (CAR) T-cells have shown great promise in the treatment of B-cell malignancies. For acute myeloid leukemia (AML), however, the optimal target surface antigen has yet to be discovered. Alternatively, T-cell receptor (TCR)-red
Externí odkaz:
https://doaj.org/article/8a9e6e8dd9154340bb2f53f8c0e0027b
Autor:
Yasmine Van Caeneghem, Stijn De Munter, Paola Tieppo, Glenn Goetgeluk, Karin Weening, Greet Verstichel, Sarah Bonte, Tom Taghon, Georges Leclercq, Tessa Kerre, Reno Debets, David Vermijlen, Hinrich Abken, Bart Vandekerckhove
Publikováno v:
OncoImmunology, Vol 6, Iss 3 (2017)
Recent clinical studies indicate that adoptive T-cell therapy and especially chimeric antigen receptor (CAR) T-cell therapy is a very potent and potentially curative treatment for B-lineage hematologic malignancies. Currently, autologous peripheral b
Externí odkaz:
https://doaj.org/article/20e75ad2cb564c7c8a949cd5e8b92798
Autor:
Lore Billiet, Laurenz De Cock, Guillem Sanchez Sanchez, Rupert L. Mayer, Glenn Goetgeluk, Stijn De Munter, Melissa Pille, Joline Ingels, Hanne Jansen, Karin Weening, Eva Pascal, Killian Raes, Sarah Bonte, Tessa Kerre, Niels Vandamme, Ruth Seurinck, Jana Roels, Marieke Lavaert, Filip Van Nieuwerburgh, Georges Leclercq, Tom Taghon, Francis Impens, Björn Menten, David Vermijlen, Bart Vandekerckhove
Publikováno v:
JOURNAL OF EXPERIMENTAL MEDICINE
Billiet et al. identify the post-thymic progeny of the agonist-selected CD10(+) PD-1(+) precursors in humans based on shared characteristics of the T cell receptor repertoire and the transcriptome. This lineage represents a well-defined but heterogen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3eb2709fc96a8b395ba17769f1460ee0
https://biblio.ugent.be/publication/01H32AFRDVK3SC2WQW4NA0DG5Z/file/01H32AGM1QN46XV5BFJWVGT2X3
https://biblio.ugent.be/publication/01H32AFRDVK3SC2WQW4NA0DG5Z/file/01H32AGM1QN46XV5BFJWVGT2X3
Autor:
Lore Billiet, Laurenz De Cock, Guillem Sanchez Sanchez, Rupert L. Mayer, Glenn Goetgeluk, Stijn De Munter, Melissa Pille, Joline Ingels, Hanne Jansen, Karin Weening, Eva Pascal, Killian Raes, Sarah Bonte, Tessa Kerre, Niels Vandamme, Ruth Seurinck, Jana Roels, Marieke Lavaert, Filip Van Nieuwerburgh, Georges Leclercq, Tom Taghon, Francis Impens, Björn Menten, David Vermijlen, Bart Vandekerckhhove
In the human thymus, a CD10+ PD-1+ TCRαβ+ differentiation pathway diverges from the conventional single positive T cell lineages at the early double positive stage. These cells are phenotypically and functionally similar to murine unconventional in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6aa90518c258da3c0d8b6420ba87e9db
https://doi.org/10.1101/2022.05.24.492634
https://doi.org/10.1101/2022.05.24.492634
Autor:
Stijn De Munter, Tessa Kerre, Lore Billiet, Hanne Jansen, Georges Leclercq, Joline Ingels, Sarah Bonte, Karin Weening, Glenn Goetgeluk, Tom Taghon, Bart Vandekerckhove, Laurenz De Cock, Melissa Pille
Publikováno v:
Oncoimmunology
article-version (VoR) Version of Record
OncoImmunology, Vol 10, Iss 1 (2021)
ONCOIMMUNOLOGY
article-version (VoR) Version of Record
OncoImmunology, Vol 10, Iss 1 (2021)
ONCOIMMUNOLOGY
T cell receptor (TCR)-redirected T cells target intracellular antigens such as Wilms’ tumor 1 (WT1), a tumor-associated antigen overexpressed in several malignancies, including acute myeloid leukemia (AML). For both chimeric antigen receptor (CAR)-
Autor:
Karim Vermaelen, Marieke Brusseel, Stijn De Munter, Melissa Pille, Joline Ingels, Saskia De Smet, Karin Weening, Glenn Goetgeluk, Rupert L. Mayer, Sarah Bonte, Kelly Heyns, Björn Menten, Tom Taghon, Nele Lootens, Sandra Van Lint, Bart Vandekerckhove, Pam Devreker, Francis Impens, Hanne Jansen, Laurenz De Cock, Georges Leclercq, Lore Billiet
Publikováno v:
CYTOTHERAPY
Messenger RNA (mRNA) has become a promising tool in therapeutic cancer vaccine strategies. Owing to its flexible design and rapid production, mRNA is an attractive antigen delivery format for cancer vaccines targeting mutated peptides expressed in a
Autor:
Lore, Billiet, Glenn, Goetgeluk, Sarah, Bonte, Stijn, De Munter, Laurenz, De Cock, Melissa, Pille, Joline, Ingels, Hanne, Jansen, Karin, Weening, Filip, Van Nieuwerburgh, Tessa, Kerre, Tom, Taghon, Georges, Leclercq, Bart, Vandekerckhove
Publikováno v:
International Journal of Molecular Sciences
Human thymic CD8αα+ CD10+ PD-1+ αβ T cells selected through early agonist selection have been proposed as the putative thymic precursors of the human CD8αα+ intestinal intraepithelial lymphocytes (IELs). However, the progeny of these thymic pre
Autor:
Tessa Kerre, Joline Ingels, Tom Taghon, Glenn Goetgeluk, Stijn De Munter, Sarah Bonte, Melissa Pille, Lore Billiet, Bart Vandekerckhove, Georges Leclercq
Publikováno v:
ONCOIMMUNOLOGY
OncoImmunology, Vol 9, Iss 1 (2020)
OncoImmunology, Vol 9, Iss 1 (2020)
Chimeric antigen receptor (CAR) T-cells have shown great promise in the treatment of B-cell malignancies. For acute myeloid leukemia (AML), however, the optimal target surface antigen has yet to be discovered. Alternatively, T-cell receptor (TCR)-red